Sinefungin is a DNA methyltransferase (Dnmt) inhibitor and an analog of s-adenosyl-L-methionine (SAM) as indicated by previous studies. In studies investigating cytosine deamination by Dnmt, it was noted that the presence of sinefungin increased the rate of deamination 103 fold in the presence of its analog SAM, and 104 in the absence of SAM. This may suggest that sinefungin could be useful as a test compound in antiviral, anticancer, antiparasitic and antifungal applications. Additional studies indicate that sinefungin was able to inhibit RNA synthesis in a vaccinia virion preparation.
1. Pugh, C.S., et al. 1978. J. Biol. Chem. 253: 4075-4077. PMID: 659406
2. Zingg, J.M., et al. 1996. Nucleic Acids Res. 24: 3267-3275. PMID: 8774911
3. Lin, Q., et al. 2001. J. Am. Chem. Soc. 123: 11608-11613. PMID: 11716715
4. Cheng, D., et al. 2004. J. Biol. Chem. 279: 23892-23899. PMID: 15056663
See how others have used Sinefungin. Click on the entry to view the PubMed entry .
PMID: # 26202969 Liu, RJ. et al. 2015. Nucleic acids research. 43: 7489-503.
PMID: # 25050323 Yadav, MK. et al. 2014. BioMed research international. 2014: 156987.
PMID: # 24128079 Fu, X. et al. 2014. Mol Ecol Resour. 14: 184-98.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.